Your session is about to expire
← Back to Search
Atenolol for Osteoporosis Prevention (APO Trial)
APO Trial Summary
This trial will evaluate whether atenolol prevents bone loss in postmenopausal women.
APO Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowAPO Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.APO Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a significant health condition like severe liver, kidney disease, or cancer.I am between 50 and 75 years old.I am between 50 and 75 years old.I am between 50 and 75 years old.My kidney function is reduced, with an eGFR below 45.I have diabetes and need insulin.I am a postmenopausal woman.I am a postmenopausal woman.
- Group 1: Atenolol
- Group 2: Placebo
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the scientific research community's consensus on Atenolol 50 MG?
"There are presently seven clinical trials investigating Atenolol 50 MG, with two of them being in Phase 3. The majority of the trials for Atenolol 50 MG are based in Scarborough, Maine, but there are115 locations running studies for Atenolol 50 MG in total."
Atenolol 50 MG is commonly used to manage which medical condition?
"Atenolol 50 MG is the go-to medication for treating tachycardia and ventricular. However, it can also help patients that suffer from angina pectoris, coronary artery atherosclerosis, and bradycardia."
Does this experiment require participants to be over 25 years old?
"The age range that this clinical trial is accepting patients is between 50-75 years old."
Are enrollees still being accepted for this experiment?
"The listing for this clinical trial on clinicaltrials.gov confirms that it is still recruiting participants. The trial was first posted on 7/27/2021 and was last updated on 8/15/2022."
Could I take part in this scientific research?
"Investigators are looking for 420 individuals aged 50-75 who currently have healthy subjects (hs). The following inclusion criteria must also be met: Aged 50-75 years."
How many participants are being allowed into this clinical trial?
"That is correct. If you visit clinicaltrials.gov, you will see that this trial was initially posted on July 27th, 2021 and updated as recently as August 15th, 2022. The study requires 420 individuals from 3 different locations."
Has Atenolol 50 MG received FDA approval?
"Atenolol 50 MG ranks a 3 on our Power scale because it is a Phase 3 medication. This signifies that, while there is data supporting its efficacy, there are also multiple rounds of data supporting its safety."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
How responsive is this trial?
Most responsive sites:
- Columbia University Irving Medical Center: < 48 hours
Average response time
- < 2 Days
Typically responds via
Share this study with friends
Copy Link
Messenger